Inactivation of Viable Surrogates for the Select Agents Virulent Newcastle Disease Virus and Highly Pathogenic Avian Influenza Virus Using Either Commercial Lysis Buffer or Heat
- PMID: 36032057
- PMCID: PMC9134477
- DOI: 10.1177/1535676019888920
Inactivation of Viable Surrogates for the Select Agents Virulent Newcastle Disease Virus and Highly Pathogenic Avian Influenza Virus Using Either Commercial Lysis Buffer or Heat
Abstract
Introduction: Federal Select Agent Program regulations require laboratories to document a validated procedure for inactivating select agents prior to movement outside registered space. Avian influenza viruses and virulent Newcastle disease virus (vNDV) are cultured in chicken amnio-allantoic fluid (AAF), but the efficacy of commercial lysis buffers to inactivate viruses in protein-rich media has not been documented.
Objectives: We assesses the efficacy of MagMAX™ lysis buffer for inactivating highly pathogenic avian influenza virus (HPAIV) and vNDV in chicken AAF and confirm the inactivation of avian influenza in serum using heat.
Methods: Low pathogenic avian influenza virus (LPAIV) and avian paramyxovirus subtype-1 (APMV-1) were incubated with lysis buffer and tested for viability. Known viable LPAIV and APMV-1 RNA was extracted from AAF using MagMAX™-96 AI/ND Viral RNA Isolation kit, and the eluate was tested for remaining infectious agent. Finally, inactivation of LPAIV in serum was examined over 3 combinations of temperature and incubation time.
Results: MagMAX™ lysis buffer inactivated both LPAIV and APMV-1 in AAF when incubated for 30 minutes at room temperature. The full extraction process eliminated viable virus from the final RNA eluate. LPAIV in serum heated to 70°C for 30 minutes was rendered noninfectious.
Conclusion: The ability of a diagnostic laboratory to move samples from one space to another is critical to maintaining biosecurity as well as efficient laboratory workflow. Our study demonstrates a method to ensure the inactivation of viable avian influenza and avian paramyxoviruses in AAF, RNA eluate, and viable avian influenza virus in sera.
Keywords: BSL-3; Federal Select Agent Program; biological select agents and toxins; biorisk management; infectious agent; pathogen.
© ABSA International 2019.
Figures
References
-
- Centers for Disease Control and United States Department of Agriculture. Federal Select Agent Program. 2017. https://www.selectagents.gov. Accessed September 16, 2017.
-
- Centers for Disease Control and United States Department of Agriculture. Agriculture: possession, use, and transfer of select agents and toxins. Fed Regist. 2005;70 FR 13278. Codified at 7 CFR § 331.
-
- Centers for Disease Control and United States Department of Agriculture. Animal and animal products: possession, use, and transfer of select agents and toxins. Fed Regist. 2005;70 FR 13284. Codified at 9 CFR § 121.
-
- Centers for Disease Control and United States Department of Agriculture. Public health: possession, use, and transfer of select agents and toxins. Fed Regist. 2005;70 FR 13316. Codified at 42 CFR § 73.
-
- United States Department of Health and Human Services, Public Health Service. Biosafety in microbiological and biomedical laboratories. 5th ed. 2009. HHS Pub No. (CDC 21-1112). https://www.cdc.gov/biosafety/publications/bmbl5/BMBL.pdf. Accessed September 17, 2017.
LinkOut - more resources
Full Text Sources